Gene Editing Market Outlook: Biotech & Pharma to be the Leading End-User
https://gminsights.wordpress.com/2017/02/09/gene-editing-market/
Recombinetics Awarded Two NIH Grants to Develop Humanized Swine Models of Alzheimer’s Disease and Neurofibromatosis 2
Recombinetics announces the receipt of two Small Business Innovative Research (SBIR) grant awards from the National Institutes of Health totaling more than $700,000. The first grant from the National Institute on Aging is to develop a genetically accurate swine model of Alzheimer’s disease. The second grant from the National Institute [...]